UCB S.A.: Epilepsies, Partial trials

The registry lists 31 Epilepsies, Partial studies with UCB S.A. as lead sponsor. 0 are open to participants now and 19 have results posted.

Phase 2 9Phase 3 13Phase 4 7No phase 4(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• An Open-label Extension Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal EpilepsyTerminatedNCT02625090Phase 2Results posted
• A Study of UCB0942 in Adult Patients With Highly Drug-resistant Focal EpilepsyCompletedNCT02495844Phase 2Results posted
• Study Evaluating Changes in Total Drug Load and Seizure Frequency Using Vimpat® (Lacosamide) in Combination TherapyCompletedNCT01673282Results posted
• Levetiracetam Versus Oxcarbazepine as Monotherapy to Evaluate Efficacy and Safety in Subjects With Newly or Recently Diagnosed Partial EpilepsyCompletedNCT01498822Phase 4Results posted
• Hormonal and Lipid Levels in Male Subjects After a Switch From Carbamazepine to LacosamideTerminatedNCT01375374Phase 3Results posted
• Trial to Assess Optimized Dosage of Lacosamide as add-on Therapy in Patients With Partial Onset SeizureCompletedNCT01235403Phase 4Results posted
• Vimpat® Added as Adjunctive Therapy to One Baseline Antiepileptic DrugCompletedNCT01098162Results posted
• Trial to Assess Lacosamide as the First add-on Anti-epileptic Drug Treatment in Patients With Partial-onset SeizuresCompletedNCT00955357Phase 4Results posted
• Post-Authorization Safety Study to Assess the Safety of Vimpat as add-on Therapy in Patients With Partial-onset SeizuresCompletedNCT00771927Results posted
• Safety of Intravenous Lacosamide Dose Followed by Twice Daily Oral Lacosamide in Subjects With Partial-onset SeizuresCompletedNCT00655551Phase 3Results posted
• Study to Assess the Long-term Safety of Oral Lacosamide in Subjects With Partial-onset SeizuresCompletedNCT00655486Phase 3Results posted
• To Determine Tolerability and Efficacy of Long-term Oral Lacosamide in Patients With Partial SeizuresCompletedNCT00552305Phase 2Results posted
• Determine Safety and Efficacy of Long-term Oral Lacosamide in Patients With Partial SeizuresCompletedNCT00522275Phase 3Results posted
• Open Label Safety and Efficacy Study of Levetiracetam in Patients With EpilepsyCompletedNCT00160654Phase 4Results posted
• Follow-up Study of L059 (Levetiracetam) in Epileptic Patients With Partial Onset Seizures by Open Label MethodCompletedNCT00160615Phase 3Results posted
• Long-Term, Follow-Up Study Of the Safety And Efficacy Of Levetiracetam In Children With Partial Onset SeizuresCompletedNCT00152516Phase 3Results posted
• Study With Subjects 18-65 Years Old With Partial Onset Seizures Who Are Currently Taking LevetiracetamCompletedNCT00152503Phase 2Results posted
• Study With Seletracetam (Ucb 44212) in Adult Subjects (18 to 65 Years) With Partial Onset SeizuresCompletedNCT00152451Phase 2Results posted
• A Study Of The Safety And Efficacy Of Levetiracetam (Keppra®) (Ucb L059) In Children With EpilepsyCompletedNCT00150709Phase 3Results posted
• Compassionate Use Program With Lacosamide in Patients With Partial-onset or Generalized Tonic-clonic SeizuresNo longer availableNCT03559673
• Pharmacovigilance Study of Keppra. SPAIN - SKATE : Safety of Keppra as Adjunctive Therapy in EpilepsyCompletedNCT00643500Phase 4
• Trial to Evaluate the Safety and Efficacy of Keppra After Conversion to Mono-therapy in Subjects With Partial EpilepsyCompletedNCT00630357Phase 4
• A Study to Evaluate the Efficacy and Safety of Seletracetam in Adult Patients With Refractory Partial Onset SeizuresWithdrawnNCT00422110Phase 2/3
• A Double-blind Confirmatory Trial of Levetiracetam in Epilepsy Patients With Partial Onset SeizuresCompletedNCT00280696Phase 3
• Determine Effects of Adjunctive Levetiracetam on Sleep Architecture in Adults With Partial Onset Epilepsy.CompletedNCT00245713Phase 4
• A Study of Brivaracetam in Subjects With Partial Onset SeizuresCompletedNCT00175929Phase 2
• A Placebo-controlled Study of Levetiracetam In Children (1mo to 4yrs of Age) With Partial Onset Seizures.CompletedNCT00175890Phase 3
• Open Label Safety and Efficacy Study of Levetiracetam in Korean Patients With EpilepsyCompletedNCT00160628Phase 3
• Double-blind, Placebo-controlled Study of Levetiracetam in Adults With POSCompletedNCT00152373Phase 3
• Safety and Tolerability of Intravenous SPM 927 as Replacement for Oral SPM 927 in Subjects With Partial SeizuresCompletedNCT00151879Phase 2/3
• A 19-week Cognition Study of Levetiracetam in Children With Partial Onset SeizuresCompletedNCT00105040Phase 2